Showing results (261-270 of 369) with videos related to
Sort By:
Pageof 37
European Urology Oncology|August 2, 2024
Clinical, Imaging, and Technical Factors Associated with Successful Genomic Profiling of Bone Biopsy Tissue in Prostate CancerFourat Ridouani, H Alberto Vargas, Daniel J Holzwanger, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2020
Oncogenic Genomic Alterations, Clinical Phenotypes, and Outcomes in Metastatic Castration-Sensitive Prostate CancerKonrad H Stopsack, Subhiksha Nandakumar, Andreas G Wibmer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2010
Phase II multicenter study of abiraterone acetate plus prednisone therapy in patients with docetaxel-treated castration-resistant prostate cancerDaniel C Danila, Michael J Morris, Johann S de Bono, et al.Cancer Research|July 23, 2003
Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapseSusan M Henshall, Daniel E H Afar, Jordan Hiller, et al.Lancet (London, England)|April 20, 2010
Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 studyHoward I Scher, Tomasz M Beer, Celestia S Higano, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2015
Improvements in Radiographic Progression-Free Survival Stratified by ERG Gene Status in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Abiraterone AcetateGerhardt Attard, Johann S de Bono, Christopher J Logothetis, et al.Science (New York, N.Y.)|April 11, 2009
Development of a second-generation antiandrogen for treatment of advanced prostate cancerChris Tran, Samedy Ouk, Nicola J Clegg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2008
Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working GroupHoward I Scher, Susan Halabi, Ian Tannock, et al.The Journal of Urology|March 28, 2023
Clinical Impact of a Rapid Genetic Testing Model for Advanced Prostate Cancer PatientsKelsey E Breen, Heather Symecko, Kelsey Spielman, et al.Cancer Research|June 15, 2026
Reprogramming of TLR-Ferroptosis Signaling and Immunometabolic Pathways Overcomes Myeloid Suppression to Improve Checkpoint Blockade in Prostate CancerNabil A Siddiqui, Li Zhang, Gabriel DeLeon, et al.Pageof 37